Top

08-05-2024 | Pneumonia | EM - ORIGINAL

Bidirectional association between pneumonia and intestinal infection: an analysis of the MIMIC-IV database

Authors: Weiqian Hou, Yi Zhu, Xigui Lai, Yujie Yang

Published in: Internal and Emergency Medicine

Abstract

The purpose is to analyze the prevalence of intestinal infection in patients with pneumonia in intensive care units (ICU) and the impact of intestinal infection on the prognosis of patients with pneumonia, so as to explore the bidirectional association between pneumonia and intestinal infection. The study aims to investigate the correlation between the occurrence of pneumonia and intestinal infection among patients in the ICU, utilizing the Medical Information Mart for Intensive Care IV (MIMIC-IV) database, as well as the impact of intestinal infection on the prognosis of pneumonia patients. The enrolled patients were first divided into pneumonia group and non-pneumonia group, and the primary outcome was that patients developed intestinal infection. Multivariate logistic regression was used to elucidate the association between pneumonia and the prevalence of intestinal infection, and propensity score matching (PSM) and inverse probability of treatment weighing (IPTW) were used to validate our findings. We then divided patients with pneumonia into two groups according to whether they were complicated by intestinal infection, and analyzed the effect of intestinal infection on 28-day mortality, length of ICU stay, and length of hospital stay in patients with pneumonia. This study included 50,920 patients, of which 7493 were diagnosed with pneumonia. Compared with non-pneumonia patients, the incidence of intestinal infection in pneumonia patients was significantly increased [OR 1.58 (95% CI 1.34–1.85; P < 0.001)]. Cox proportional hazards regression model showed no significant effect of co-infection on 28-day mortality in patients with pneumonia (P = 0.223). Patients in the intestinal infection group exhibited a longer length stay in ICU and hospital than those without intestinal infection (P < 0.001). In the ICU, patients with pneumonia were more likely linked to intestinal infection. In addition, the presence of concurrent intestinal infections can prolong both ICU and hospital stays for pneumonia patients.

Available only for authorised users

Blot S, Ruppé E, Harbarth S, Asehnoune K, Poulakou G, Luyt CE et al (2022) Healthcare-associated infections in adult intensive care unit patients: changes in epidemiology, diagnosis, prevention and contributions of new technologies. Intensive Crit Care Nurs 70:103227. https://doi.org/10.1016/j.iccn.2022.103227CrossRefPubMedPubMedCentral

Hespanhol V, Bárbara C (2020) Pneumonia mortality, comorbidities matter? Pulmonology 26(3):123–129. https://doi.org/10.1016/j.pulmoe.2019.10.003CrossRefPubMed

Myrianthefs P, Zakynthinos GE, Tsolaki V, Makris D (2023) Aerosolized antibiotics to manage ventilator-associated infections: a comprehensive review. Antibiotics (Basel) 12(5):801. https://doi.org/10.3390/antibiotics12050801CrossRefPubMed

Pottier V, Daubin C, Lerolle N, Gaillard C, Viquesnel G, Plaud B et al (2012) Overview of adverse events related to invasive procedures in the intensive care unit. Am J Infect Control 40(3):241–246. https://doi.org/10.1016/j.ajic.2011.04.005CrossRefPubMed

Wang L, Pelgrim CE, Peralta Marzal LN, Korver S, van Ark I, Leusink-Muis T et al (2022) Changes in intestinal homeostasis and immunity in a cigarette smoke- and LPS-induced murine model for COPD: the lung-gut axis. Am J Physiol Lung Cell Mol Physiol 323(3):L266-l280. https://doi.org/10.1152/ajplung.00486.2021CrossRefPubMedPubMedCentral

Wang J, Li F, Wei H, Lian ZX, Sun R, Tian Z (2014) Respiratory influenza virus infection induces intestinal immune injury via microbiota-mediated Th17 cell-dependent inflammation. J Exp Med 211(12):2397–2410. https://doi.org/10.1084/jem.20140625CrossRefPubMedPubMedCentral

Wu T, Xu F, Su C, Li H, Lv N, Liu Y et al (2020) Alterations in the gut microbiome and cecal metabolome during Klebsiella pneumoniae-induced Pneumosepsis. Front Immunol 11:1331. https://doi.org/10.3389/fimmu.2020.01331CrossRefPubMedPubMedCentral

Villafuerte D, Aliberti S, Soni NJ, Faverio P, Marcos PJ, Wunderink RG et al (2020) Prevalence and risk factors for Enterobacteriaceae in patients hospitalized with community-acquired pneumonia. Respirology 25(5):543–551. https://doi.org/10.1111/resp.13663CrossRefPubMed

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J et al (2020) Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in wuhan. China Jama 323(11):1061–1069. https://doi.org/10.1001/jama.2020.1585CrossRefPubMed

10.

Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y et al (2020) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395(10223):507–513. https://doi.org/10.1016/s0140-6736(20)30211-7CrossRefPubMedPubMedCentral

11.

Clark JA, Coopersmith CM (2007) Intestinal crosstalk: a new paradigm for understanding the gut as the “motor” of critical illness. Shock 28(4):384–393. https://doi.org/10.1097/shk.0b013e31805569dfCrossRefPubMedPubMedCentral

12.

Otani S, Coopersmith CM (2019) Gut integrity in critical illness. J Intensive Care 7:17. https://doi.org/10.1186/s40560-019-0372-6CrossRefPubMedPubMedCentral

13.

Aardema H, Lisotto P, Kurilshikov A, Diepeveen JRJ, Friedrich AW, Sinha B et al (2019) Marked changes in gut microbiota in cardio-surgical intensive care patients: a longitudinal cohort study. Front Cell Infect Microbiol 9:467. https://doi.org/10.3389/fcimb.2019.00467CrossRefPubMed

14.

Zanza C, Romenskaya T, Thangathurai D, Ojetti V, Saviano A, Abenavoli L et al (2022) Microbiome in critical care: an unconventional and unknown ally. Curr Med Chem 29(18):3179–3188. https://doi.org/10.2174/0929867328666210915115056CrossRefPubMed

15.

Tamburini S, Clemente JC (2017) Gut microbiota: Neonatal gut microbiota induces lung immunity against pneumonia. Nat Rev Gastroenterol Hepatol 14(5):263–264. https://doi.org/10.1038/nrgastro.2017.34CrossRefPubMed

16.

Dickson RP, Singer BH, Newstead MW, Falkowski NR, Erb-Downward JR, Standiford TJ et al (2016) Enrichment of the lung microbiome with gut bacteria in sepsis and the acute respiratory distress syndrome. Nat Microbiol 1(10):16113. https://doi.org/10.1038/nmicrobiol.2016.113CrossRefPubMedPubMedCentral

17.

Chakradhar S (2017) A curious connection: teasing apart the link between gut microbes and lung disease. Nat Med 23(4):402–404. https://doi.org/10.1038/nm0417-402CrossRefPubMed

18.

Wang X, Zhou Y, Jiang N, Zhou Q, Ma WL (2020) Persistence of intestinal SARS-CoV-2 infection in patients with COVID-19 leads to re-admission after pneumonia resolved. Int J Infect Dis 95:433–435. https://doi.org/10.1016/j.ijid.2020.04.063CrossRefPubMedPubMedCentral

19.

Khan N, Vallarino C, Lissoos T, Darr U, Luo M (2020) Risk of infection and types of infection among elderly patients with inflammatory bowel disease: a retrospective database analysis. Inflamm Bowel Dis 26(3):462–468. https://doi.org/10.1093/ibd/izz065CrossRefPubMed

20.

Khan N, Patel D, Trivedi C, Pernes T, Kavani H, Xie D et al (2022) The impact of IBD medications on risk of pneumonia and pneumonia-related hospitalisation: a nationwide cohort study of 56 410 IBD patients. Aliment Pharmacol Ther 55(1):64–72. https://doi.org/10.1111/apt.16610CrossRefPubMed

21.

Ittisanyakorn M, Ruchichanantakul S, Vanichkulbodee A, Sri-On J (2019) Prevalence and factors associated with one-year mortality of infectious diseases among elderly emergency department patients in a middle-income country. BMC Infect Dis 19(1):662. https://doi.org/10.1186/s12879-019-4301-zCrossRefPubMedPubMedCentral

22.

Johnson AEW, Bulgarelli L, Shen L, Gayles A, Shammout A, Horng S et al (2023) MIMIC-IV, a freely accessible electronic health record dataset. Sci Data 10(1):1. https://doi.org/10.1038/s41597-022-01899-xCrossRefPubMedPubMedCentral

23.

Mayer M, Mayer MM (2019) Package ‘missRanger’. R Package. https://github.com/mayer79/missRanger

24.

Zhang Z (2017) Propensity score method: a non-parametric technique to reduce model dependence. Ann Transl Med 5(1):7. https://doi.org/10.21037/atm.2016.08.57CrossRefPubMedPubMedCentral

25.

Grafféo N, Latouche A, Le Tourneau C, Chevret S (2019) ipcwswitch: an R package for inverse probability of censoring weighting with an application to switches in clinical trials. Comput Biol Med 111:103339. https://doi.org/10.1016/j.compbiomed.2019.103339CrossRefPubMed

26.

Moffatt MF, Cookson WO (2017) The lung microbiome in health and disease. Clin Med (Lond) 17(6):525–529. https://doi.org/10.7861/clinmedicine.17-6-525CrossRefPubMed

27.

Groves HT, Cuthbertson L, James P, Moffatt MF, Cox MJ, Tregoning JS (2018) Respiratory disease following viral lung infection alters the murine gut microbiota. Front Immunol 9:182. https://doi.org/10.3389/fimmu.2018.00182CrossRefPubMedPubMedCentral

28.

Hanada S, Pirzadeh M, Carver KY, Deng JC (2018) Respiratory viral infection-induced microbiome alterations and secondary bacterial pneumonia. Front Immunol 9:2640. https://doi.org/10.3389/fimmu.2018.02640CrossRefPubMedPubMedCentral

29.

Lv Z, Xiong D, Shi J, Long M, Chen Z (2021) The interaction between viruses and intestinal microbiota: a review. Curr Microbiol 78(10):3597–3608. https://doi.org/10.1007/s00284-021-02623-5CrossRefPubMedPubMedCentral

30.

Zhu W, Wu Y, Liu H, Jiang C, Huo L (2021) Gut-lung axis: microbial crosstalk in pediatric respiratory tract infections. Front Immunol 12:741233. https://doi.org/10.3389/fimmu.2021.741233CrossRefPubMedPubMedCentral

31.

Dilantika C, Sedyaningsih ER, Kasper MR, Agtini M, Listiyaningsih E, Uyeki TM et al (2010) Influenza virus infection among pediatric patients reporting diarrhea and influenza-like illness. BMC Infect Dis 10:3. https://doi.org/10.1186/1471-2334-10-3CrossRefPubMedPubMedCentral

32.

Groves HT, Higham SL, Moffatt MF, Cox MJ, Tregoning JS (2020) Respiratory Viral Infection Alters the Gut Microbiota by Inducing Inappetence. MBio 11(1):10–1128. https://doi.org/10.1128/mBio.03236-19CrossRef

33.

von Baum H, Welte T, Marre R, Suttorp N, Ewig S (2010) Community-acquired pneumonia through Enterobacteriaceae and Pseudomonas aeruginosa: diagnosis, incidence and predictors. Eur Respir J 35(3):598–605. https://doi.org/10.1183/09031936.00091809CrossRef

34.

Falguera M, Carratalà J, Ruiz-Gonzalez A, Garcia-Vidal C, Gazquez I, Dorca J et al (2009) Risk factors and outcome of community-acquired pneumonia due to gram-negative bacilli. Respirology 14(1):105–111. https://doi.org/10.1111/j.1440-1843.2008.01371.xCrossRefPubMed

35.

Silva YP, Bernardi A, Frozza RL (2020) The role of short-chain fatty acids from gut microbiota in gut-brain communication. Front Endocrinol (Lausanne) 11:25. https://doi.org/10.3389/fendo.2020.00025CrossRefPubMed

36.

Parada Venegas D, De la Fuente MK, Landskron G, González MJ, Quera R, Dijkstra G et al (2019) Short chain fatty acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases. Front Immunol 10:277. https://doi.org/10.3389/fimmu.2019.00277CrossRefPubMedPubMedCentral

37.

Zhao X, Hu M, Zhou H, Yang Y, Shen S, You Y et al (2023) The role of gut microbiome in the complex relationship between respiratory tract infection and asthma. Front Microbiol 14:1219942. https://doi.org/10.3389/fmicb.2023.1219942CrossRefPubMedPubMedCentral

38.

Wu D, Zhou K, Xiao M, Liu Z, Zhang S (2022) Differences in intestinal microbiome are associated with the mortality of COVID-19 patients in intensive care units. Sci China Life Sci 65(5):1040–1042. https://doi.org/10.1007/s11427-021-2072-4CrossRefPubMedPubMedCentral

39.

Nobel YR, Phipps M, Zucker J, Lebwohl B, Wang TC, Sobieszczyk ME et al (2020) Gastrointestinal symptoms and coronavirus disease 2019: a case-control study from the United States. Gastroenterology 159(1):373-375.e372. https://doi.org/10.1053/j.gastro.2020.04.017CrossRefPubMed

40.

Laszkowska M, Faye AS, Kim J, Truong H, Silver ER, Ingram M et al (2021) Disease course and outcomes of COVID-19 among hospitalized patients with gastrointestinal manifestations. Clin Gastroenterol Hepatol 19(7):1402-1409.e1401. https://doi.org/10.1016/j.cgh.2020.09.037CrossRefPubMed

41.

Hu F, Chen F, Ou Z, Fan Q, Tan X, Wang Y et al (2020) A compromised specific humoral immune response against the SARS-CoV-2 receptor-binding domain is related to viral persistence and periodic shedding in the gastrointestinal tract. Cell Mol Immunol 17(11):1119–1125. https://doi.org/10.1038/s41423-020-00550-2CrossRefPubMed

42.

Osman AA, Al Daajani MM, Alsahafi AJ (2020) Re-positive coronavirus disease 2019 PCR test: could it be a reinfection? New Microbes New Infect 37:100748. https://doi.org/10.1016/j.nmni.2020.100748CrossRefPubMedPubMedCentral

43.

Freedberg DE, Zhou MJ, Cohen ME, Annavajhala MK, Khan S, Moscoso DI et al (2018) Pathogen colonization of the gastrointestinal microbiome at intensive care unit admission and risk for subsequent death or infection. Intensive Care Med 44(8):1203–1211. https://doi.org/10.1007/s00134-018-5268-8CrossRefPubMedPubMedCentral

44.

Trivedi S, Grossmann AH, Jensen O, Cody MJ, Wahlig TA, Hayakawa Serpa P et al (2021) Intestinal infection is associated with impaired lung innate immunity to secondary respiratory infection. Open Forum Infect Dis 8(6):ofab237. https://doi.org/10.1093/ofid/ofab237CrossRefPubMedPubMedCentral

45.

Bron PA, van Baarlen P, Kleerebezem M (2011) Emerging molecular insights into the interaction between probiotics and the host intestinal mucosa. Nat Rev Microbiol 10(1):66–78. https://doi.org/10.1038/nrmicro2690CrossRefPubMed

46.

Mullish BH, Marchesi JR, McDonald JAK, Pass DA, Masetti G, Michael DR et al (2021) Probiotics reduce self-reported symptoms of upper respiratory tract infection in overweight and obese adults: should we be considering probiotics during viral pandemics? Gut Microbes 13(1):1–9. https://doi.org/10.1080/19490976.2021.1900997CrossRefPubMed

47.

Batra P, Soni KD, Mathur P (2020) Efficacy of probiotics in the prevention of VAP in critically ill ICU patients: an updated systematic review and meta-analysis of randomized control trials. J Intensive Care 8:81. https://doi.org/10.1186/s40560-020-00487-8CrossRefPubMedPubMedCentral

Title: Bidirectional association between pneumonia and intestinal infection: an analysis of the MIMIC-IV database
Authors: Weiqian Hou
Yi Zhu
Xigui Lai
Yujie Yang
Publication date: 08-05-2024
Publisher: Springer International Publishing
Keyword: Pneumonia
Published in: Internal and Emergency Medicine
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI: https://doi.org/10.1007/s11739-024-03631-6

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials